Email Newsletters

Framingham

Framingham firm receives N.Y. certification

Framingham-based Boston Heart Diagnostics Corp. announced it can now serve patients with its diagnostics into personalized nutrition...

Bose sues over alleged patent infringement

Bose Corp. filed a lawsuit last week against Monster Inc., accusing the California-based rival of infringing on the Framingham-based audio technology company's design for in-ear headphones.

Ambulance provider expands to Ashland

Fallon Ambulance Service, based in Boston's South Shore suburbs, is expanding west to a new location in Ashland after it was selected as the emergency medical services provider for MetroWest Medical Center, Fallon announced.

Report: Wearable tech market to grow by 78%

While it was a rage at the Consumer Electronic Show, wearable technology is seen as being primarily in its infancy. But a report from Framingham-based technology research firm International Data Corporation (IDC), says that the worldwide wearable computing market is finally expanding beyond early adopter status, especially for the complex accessory market led by companies such as Nike and FitBit.
ADVERTISEMENT

Genzyme to reapply for MS drug approval

Genzyme plans to resubmit its application to U.S. regulators for its multiple sclerosis (MS) treatment, the Cambridge-based drug maker said Monday.

Feds to probe alleged infringement of Bose patent

The U.S. International Trade Commission (ITC) announced March 31 that it will launch an investigation into a patent infringement claim by Framingham-based audio technology company Bose Corp. Bose alleged in a Feb. 26 complaint that California-based Monster Inc.'s iSport Intensity in-ear headphones violate a patent for a device that keeps earpieces inside a user's ear without using ear hooks or “twist lock” tips, which can be uncomfortable or fit poorly. The device can be found in Bose's Bluetooth headsets, sport headphones and noise-cancelling headphones, according to Bose.

Alnylam makes progress on gene therapy in Europe

Alnylam Pharmaceuticals Inc., a Cambridge company that has allied with Genzyme to develop RNAi therapeutics across the world, has received a positive opinion from European officials on an application for orphan drug status to treat a rare genetic disease that causes fatal organ and nerve damage.

Bose selected as NFL headset provider

Framingham-based Bose Corp. announced this week that they will serve as the NFL's headphone and headset provider starting this season.
ADVERTISEMENT

Genzyme makes $23-million stock purchase

Cambridge-based biotechnology firm Genzyme announced the purchase of $23 million in stock from Alnylam Pharmaceuticals Inc.

TJX recalls light-up decorations

TJX Cos. of Framingham is recalling 4,600 Gardeners Eden brand light-up autumn decorations that can short circuit and pose a fire risk, U.S. regulators said.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA